FluidForm Bio™ Announces Participation in the New England Venture Summit
December 06, 2024 08:00 ET
|
FluidForm Bio
WALTHAM, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will...